Sensus Healthcare (NASDAQ:SRTS) Stock Price Crosses Below 50 Day Moving Average – Here’s Why

Sensus Healthcare, Inc. (NASDAQ:SRTS)’s share price passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $5.63 and traded as low as $4.57. Sensus Healthcare shares last traded at $4.77, with a volume of 130,239 shares changing hands.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the company. Lake Street Capital decreased their target price on Sensus Healthcare from $18.00 to $13.00 and set a “buy” rating on the stock in a research note on Tuesday, March 11th. HC Wainwright upped their target price on shares of Sensus Healthcare from $11.00 to $12.00 and gave the stock a “buy” rating in a research report on Monday, February 10th.

Sensus Healthcare Price Performance

The company has a market capitalization of $78.68 million, a PE ratio of 11.93 and a beta of 1.28. The business has a 50-day moving average of $5.63 and a 200 day moving average of $6.55.

Sensus Healthcare (NASDAQ:SRTS) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.09 EPS for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.01). Sensus Healthcare had a return on equity of 12.60% and a net margin of 15.90%. As a group, research analysts anticipate that Sensus Healthcare, Inc. will post 0.32 EPS for the current year.

Institutional Trading of Sensus Healthcare

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. JPMorgan Chase & Co. purchased a new position in shares of Sensus Healthcare during the 4th quarter worth about $27,000. Barclays PLC purchased a new position in shares of Sensus Healthcare during the fourth quarter valued at approximately $35,000. BNP Paribas Financial Markets bought a new position in shares of Sensus Healthcare during the fourth quarter valued at approximately $47,000. IFP Advisors Inc purchased a new stake in shares of Sensus Healthcare in the fourth quarter worth approximately $95,000. Finally, NewEdge Advisors LLC purchased a new position in Sensus Healthcare during the 4th quarter valued at $109,000. Hedge funds and other institutional investors own 25.30% of the company’s stock.

Sensus Healthcare Company Profile

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.